Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord Blood Mononuclear Cells for Chronic Atrophic Gastritis
NCT05808010Active, not recruiting
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Jun 2023
- Primary completion
- Apr 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Randomised, open-label trial of umbilical cord blood mononuclear cells in chronic atrophic gastritis (CAG) (3 arms), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Primary endpoints: Change from baseline OLGA/OLGIM stages of gastric mucosa at 13 months and Change from baseline gastric mucosal status under gastroscope at 13 months. Started Jun 2023; status: active, not recruiting.
02
Drugs
umbilical cord blood mononuclear cells
03
Conditions
chronic atrophic gastritis (CAG)
Beyond the preview
Go deeper on NCT05808010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05808010.